Roche Diagnostics Australia   ›    Resources   ›    Pro-COAG 2022

Pro-COAG 2022

 

Venous thromboembolism risk and anticoagulation in special populations

Pro-COAG is a scientific and educational event, with top experts in the area of Coagulation, sharing their knowledge on current hot topics. Stay up-to-date on the latest global trends and most significant developments. 

The pro-COAG meeting covers topics of interest for laboratories, clinicians and healthcare institutions to facilitate shaping future pathways in the field of Coagulation and to identify unmet medical needs. We strive to empower clinicians to improve patient care and treatment and serve as an opportunity for discussions and the exchange of expert opinions. 

This year, the pro-COAG was held virtually for the second time, offering a deep dive into Coagulation. The exciting scientific program included presentations and a panel discussion focusing on the risk of venous thromboembolism (VTE) in special populations, such as pregnant women and women on hormone therapy, hospitalised and cancer patients.

Event Recordings

Risk and management of VTE in pregnancy and hormone therapy in women

 

Prof. Lai Heng Lee

Thrombosis risk and anticoagulation in hospitalised patients

 

Prof. Alex C. Spyropoulos

Thrombosis in inflammation and cancer

 

Prof. Heng Joo Ng

Panel discussion: Importance of coagulation testing in clinical practices, with a focus on special populations

All speakers

Meet the speakers

Pantep Angchaisuksiri, M.D.

Pantep Angchaisuksiri

MD

Pantep Angchaisuksiri, M.D., is a Professor of Medicine and Chief of the Hemostasis and Thrombosis Unit in the Division of Hematology, Department of Medicine, at Ramathibodi Hospital, Mahidol University in Bangkok, Thailand. He also holds posts of Adjunct Associate Professor of Medicine at the University of North Carolina at Chapel Hill, School of Medicine, USA. An active clinician, Professor Angchaisuksiri works with patients with thrombosis and bleeding disorders. He is a council member of the International Society on Thrombosis and Haemostasis (ISTH) and the Asian-Pacific Society on Thrombosis and Hemostasis (APSTH). He is also ISTH President for the 2024-2026 term, and chair of the ISTH Education and Outreach Committee.

Lee Lai Heng

Lai Heng Lee

MBBS, MMed, FRCP(Edin), FAMS

Prof. Lee received her medical and advanced specialist training in haematology in Singapore. She is previously head and currently a senior consultant with the Department of Haematology at Singapore General Hospital. Her keen interest in coagulation disorders resulted in numerous publications and she played a key role in clinical trials in novel anticoagulants in Singapore and the Asia Pacific. She was instrumental in the setting up of the anticoagulation clinic, promoting patient safety in anticoagulation therapy and developing the subspecialty of Thrombosis and Haemostasis in Singapore.  A/Prof. Lee is also actively involved in medical education in her roles as Clinical Associate Professor Yong Loo Lin School of Medicine, NUS and Adjunct Associate Professor, Duke-NUS Graduate Medical School. Besides her clinical, research, administrative and academic duties, A/Prof. Lee also participates actively in the local and regional professional scenes as Chairman of the Asia-Pacific Society for Thrombosis and Haemostasis, Chairman of the Chapter of Haematology, Council Member of the College of Physician, Singapore and past President of the Singapore Society of Haematology.

Alex C. Spyropoulos

Alex C. Spyropoulos

MD, FACP, FCCP, FRCPC

Prof. Spyropoulos was the Founder and former Medical Director of the Clinical Thrombosis Center in Albuquerque, New Mexico. He is a Professor of Medicine at the Zucker School of Medicine at Hofstra/Northwell System and Director of Anticoagulation and Clinical Thrombosis Services for the multi-hospital Northwell Health System in NY. He is also a Professor at the Center for Health Innovations and Outcomes Research/Institute for Health Systems Science as part of the Feinstein Institute for Medical Research. He is co-chair of the Council on Leadership of Thrombosis at Northwell Health System. He is a Fellow of the American College of Physicians, American College of Chest Physicians, International Academy of Clinical and Applied Thrombosis/Haemostasis, and the Royal College of Physicians, Canada.

Ng Heng Joo

Heng Joo Ng

MBBS, MMed (Int Med), MRCP (UK), FRCPath (UK), FAMS

Prof. Ng is currently a senior consultant and Head of the Department of Haematology, Singapore General Hospital (SGH). He is a Clinical Professor with the Duke-National University of Singapore (NUS) School of Medicine, and a senior lecturer with the Yong Loo Lin School of Medicine, NUS. After graduating from NUS in 1993, Prof. Ng practised in the Malaysian state of Sarawak before training in Haematology at SGH. He attained specialist accreditation in 2004 and thereafter did a year-long fellowship in thrombosis and haemostasis at McMaster University in Hamilton, Canada. His research interest is in the optimisation of anticoagulation and bleeding disorders. 

Want to stay updated on the latest coagulation topics?
Form Successfully Submitted!
Thank you for your submission!
text